These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 8239907)

  • 1. Immunoregulation of antitumor response; differential secretion of arachidonic acid metabolites by macrophages during stimulation in vitro with BCG and Corynebacterium parvum.
    Tomecki J; Sukiennik J; Kordowiak A
    Arch Immunol Ther Exp (Warsz); 1993; 41(1):45-50. PubMed ID: 8239907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitumor efficacy of activated macrophages against murine glioma cells].
    Miyao Y; Shimizu K; Okamoto Y; Matsui Y; Ushio Y; Hayakawa T; Tsuda N; Mogami H
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2082-8. PubMed ID: 3717955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulatory effect of killed Propionibacterium acnes and its purified soluble polysaccharide on peritoneal exudate cells from C57Bl/6 mice: major NKT cell recruitment and increased cytotoxicity.
    Ananias RZ; Rodrigues EG; Braga EG; Squaiella CC; Mussalem JS; Longhini AL; Travassos LR; Longo-Maugéri IM
    Scand J Immunol; 2007 Jun; 65(6):538-48. PubMed ID: 17523946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of macrophage antitumor activity by a mycobacterial fraction. In vivo and in vitro studies.
    Rashid G; Gittel H; Ben-Efraim S
    Anticancer Res; 1994; 14(3A):1083-7. PubMed ID: 8074454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective tumoricidal capacity of macrophages from A/J mice. I. Characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1979 Apr; 122(4):1587-91. PubMed ID: 376720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine IL-2 secreting recombinant Bacillus Calmette-Guerin augments macrophage-mediated cytotoxicity against murine bladder cancer MBT-2.
    Yamada H; Matsumoto S; Matsumoto T; Yamada T; Yamashita U
    J Urol; 2000 Aug; 164(2):526-31. PubMed ID: 10893638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species-restricted effects of human and mouse lymphokines on macrophages.
    Tagliabue A; Mantovani A; Boraschi D; Herberman RB
    Eur J Immunol; 1980 Jul; 10(7):542-6. PubMed ID: 6157542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Definition of tumor-necrosis factor and its production mechanism].
    Urushizaki I; Niitsu Y; Watanabe N
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1356-68. PubMed ID: 6378100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Equal sensitivity of normal or tumoral fibroblasts to cytotoxic and cytostatic effects of normal or "Corynebacterium parvum" activated peritoneal exudate cells (author's transl)].
    Fray A; Lorinet AM; Thobie N; Halpern B
    Ann Immunol (Paris); 1979; 130C(3):445-59. PubMed ID: 475346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.
    Germain RN; Williams RM; Benacerraf B
    J Natl Cancer Inst; 1975 Mar; 54(3):709-20. PubMed ID: 1091741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional heterogeneity in macrophages activated by Corynebacterium parvum: characterization of subpopulations with different activities in promoting immune responses and suppressing tumor cell growth.
    Lee KC; Berry D
    J Immunol; 1977 May; 118(5):1530-40. PubMed ID: 323353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage functions in beige (Chédiak-Higashi syndrome) mice.
    Mahoney KH; Morse SS; Morahan PS
    Cancer Res; 1980 Nov; 40(11):3934-9. PubMed ID: 7471044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
    Gabizon A; Leibovich SJ; Goldman R
    J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of the potentiation of specific antitumor immunity by intratumor injection of Corynebacterium parvum.
    Miyata H; Himeno K; Nomoto K
    Cancer Res; 1983 Oct; 43(10):4670-5. PubMed ID: 6883325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli.
    Boraschi D; Meltzer MS
    J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of cytokines and nitric oxide in the induction of tuberculostatic macrophage functions.
    Petricevich VL; Alves RC
    Mediators Inflamm; 2000; 9(6):261-9. PubMed ID: 11213909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon production by Corynebacterium parvum and BCG-activated murine spleen macrophages.
    Neumann C; Macher E; Sorg C
    Immunobiology; 1980 Apr; 157(1):12-23. PubMed ID: 6162779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro anti-tumour properties of peritoneal exudate cells of conventional germ-free and stimulated mice.
    Fray A; Lorinet AM; Halpern B
    Dev Biol Stand; 1977 Apr 13-15; 38():241-4. PubMed ID: 608509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage functions in Biozzi mice.
    Dockrell HM; Taverne J; Lelchuk R; Depledge P; Brown IN; Playfair JH
    Immunology; 1985 Jul; 55(3):501-9. PubMed ID: 3894222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.